J.W. COLE ADVISORS, INC.

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1404763 TAMPA, FL

Position in VRTX

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$702,376

+$3,541 QoQ

Shares Held

1,414

-9.6% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#294

of 646 holders

Holding Since

Mar 2021

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

J.W. COLE ADVISORS, INC. holds $3,075,638 across 11 Biotechnology names. VRTX ranks #1 (22.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	1,414	$702,376
2	REGN	Regeneron Pharmaceuticals, Inc.	958	$597,351
3	RVMD	Revolution Medicines, Inc.	2,722	$509,776
4	ACAD	Acadia Pharmaceuticals Inc	16,906	$427,721
5	EXEL	Exelixis, Inc.	5,934	$322,868
6	INCY	Incyte Corp	2,210	$250,525
7	VCEL	Vericel Corp	4,700	$209,103
8	CRBU	Caribou Biosciences, Inc.	11,269	$19,833

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$702,376	1,414	-9.6%	Shares	Sole	2026-07-21
2026-03-31	$698,835	1,565	+18.3%	Shares	Sole	2026-04-23
2025-12-31	$599,795	1,323	-11.0%	Shares	Sole	2026-02-11
2025-09-30	$582,368	1,487	-6.1%	Shares	Sole	2025-11-05
2025-06-30	$705,196	1,584	-9.6%	Shares	Sole	2025-08-12
2025-03-31	$849,889	1,753	+147.2%	Shares	Sole	2025-05-05
2024-12-31	$285,514	709	+2.9%	Shares	Sole	2025-01-31
2024-09-30	$320,440	689	-18.5%	Shares	Sole	2024-10-24
2024-06-30	$396,068	845	+8.1%	Shares	Sole	2024-08-08
2024-03-31	$326,883	782	+33.2%	Shares	Sole	2024-04-30
2023-12-31	$238,844	587	-58.1%	Shares	Sole	2024-01-31
2021-12-31	$307,879	1,402	-11.8%	Shares	Sole	2022-01-25
2021-09-30	$288,228	1,589	+11.4%	Shares	Sole	2021-10-26
2021-06-30	$287,524	1,426	+35.8%	Shares	Sole	2021-08-06
2021-03-31	$225,634	1,050	—	Shares	Sole	2021-04-28
No filing history on record for this holder in this stock.